However, there is data showing that Dectin-1 can bind to N-glycans present on tumor cells (35) and to an unknown ligand present in T cells that was resistant to tunicamycin/N-glycosidase treatment but susceptible to trypsin treatment (36), suggesting that Dectin-1 may bind to other carbohydrates than classically thought and perhaps even non-glycan components. Here, CLEC7A is linked to neoplasm.